Inspire Advisors, LLC Citius Pharmaceuticals, Inc. Transaction History
Inspire Advisors, LLC
- $681 Million
- Q2 2024
A detailed history of Inspire Advisors, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Inspire Advisors, LLC holds 158,244 shares of CTXR stock, worth $79,122. This represents 0.01% of its overall portfolio holdings.
Number of Shares
158,244
Previous 157,426
0.52%
Holding current value
$79,122
Previous $141,000
35.46%
% of portfolio
0.01%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding CTXR
# of Institutions
73Shares Held
30.6MCall Options Held
24.7KPut Options Held
0-
Armistice Capital, LLC New York, NY10.2MShares$5.08 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.33MShares$3.16 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.02 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$902,8630.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.65MShares$823,1480.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $73.1M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...